Investigating DNA Methylation of <i>SHATI/NAT8L</i> Promoter Sites in Blood of Unmedicated Patients with Major Depressive Disorder-Reference-Cited by-同舟云学术

Investigating DNA Methylation of SHATI/NAT8L Promoter Sites in Blood of Unmedicated Patients with Major Depressive Disorder

Published:2020-07-01 Issue:7 Volume:43 Page:1067-1072
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Miyanishi Hajime¹,Uno Kyosuke¹²,Iwata Mina¹,Kikuchi Yuu³,Yamamori Hidenaga³,Yasuda Yuka³,Ohi Kazutaka³,Hashimoto Ryota³⁴,Hattori Kotaro⁵,Yoshida Sumiko⁵,Goto Yu-ichi⁶,Sumiyoshi Tomiki⁶,Nitta Atsumi¹

Affiliation:

1. Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama

2. Laboratory of Molecular Pharmacology, Faculty of Pharmaceutical Sciences, Setsunan University

3. Department of Psychiatry, Osaka University Graduate School of Medicine

4. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry

5. Medical Genome Center, National Center of Neurology and Psychiatry

6. Department of Preventive Intervention, National Institute of Mental Health, National Center of Neurology and Psychiatry

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/43/7/43_b19-01099/_pdf

Reference39 articles.

1. 1) Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M. Evaluation of outcomes with citalopram for MDD using measurement-based care in STAR*D: implications for clinical practice. Am. J. Psychiatry, 163, 28–40 (2006).

2. 2) Jiang C, Lin WJ, Sadahiro M, Labonté B, Menard C, Pfau ML, Tamminga CA, Turecki G, Nestler EJ, Russo SJ, Salton SR. VGF function in MDD and antidepressant efficacy. Mol. Psychiatry, 23, 1632–1642 (2018).

3. 3) Keller MB, Gelenberg AJ, Hirschfeld RM, Rush AJ, Thase ME, Kocsis JH, Markowitz JC, Fawcett JA, Koran LM, Klein DN, Russell JM, Kornstein SG, McCullough JP, Davis SM, Harrison WM. The treatment of chronic MDD, part 2: a double-blind, randomized trial of sertraline and imipramine. J. Clin. Psychiatry, 59, 598–607 (1998).

4. 4) Keller MB, McCullough JP, Klein DN, Arnow B, Dunner DL, Gelenberg AJ, Markowitz JC, Nemeroff CB, Russell JM, Thase ME, Trivedi MH, Zajecka J. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic MDD. N. Engl. J. Med., 342, 1462–1470 (2000).

5. 5) Kaufman J, Gelernter J, Hudziak JJ, Tyrka AR, Coplan JD. The Research Domain Criteria (RDoC) project and studies of risk and resilience in maltreated children. J. Am. Acad. Child Adolesc. Psychiatry, 54, 617–625 (2015).

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of GABA in the Dorsal Striatum-Raphe Nucleus Circuit Regulating Stress Vulnerability in Male Mice with High Levels of Shati/Nat8l;eneuro;2023-10

2. DNA methylation status of SHATI/NAT8L promoter in the blood of cigarette smokers;Neuropsychopharmacology Reports;2023-09-05

3. Curcumin can improve spinal cord injury by inhibiting DNA methylation;Molecular and Cellular Biochemistry;2023-04-19

4. DNA Methylation in Depression and Depressive-Like Phenotype: Biomarker or Target of Pharmacological Intervention?;Current Neuropharmacology;2022-12

5. N-Acetyl Transferase, Shati/Nat8l, in the Dorsal Hippocampus Suppresses Aging-induced Impairment of Cognitive Function in Mice;Neurochemical Research;2022-04-15